Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

A Prediction Model for Nodal Disease among Patients with Non-Small Cell Lung Cancer.

Verdial F, Madtes D, Hwang B, Mulligan M, Odem-Davis K, Waworuntu R, Wood D, Farjah F.

Ann Thorac Surg. 2019 Jan 30. pii: S0003-4975(19)30111-0. doi: 10.1016/j.athoracsur.2018.12.041. [Epub ahead of print]

PMID:
30710518
2.

Role of bleeding recognition and evaluation in Black-White disparities in endometrial cancer.

Doll KM, Khor S, Odem-Davis K, He H, Wolff EM, Flum DR, Ramsey SD, Goff BA.

Am J Obstet Gynecol. 2018 Dec;219(6):593.e1-593.e14. doi: 10.1016/j.ajog.2018.09.040. Epub 2018 Oct 3.

PMID:
30291839
3.

Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.

Thornblade LW, Mulligan MS, Odem-Davis K, Hwang B, Waworuntu RL, Wolff EM, Kessler L, Wood DE, Farjah F.

Ann Thorac Surg. 2018 Nov;106(5):1460-1467. doi: 10.1016/j.athoracsur.2018.06.022. Epub 2018 Jul 19.

4.

Bioactive lipids accumulate in stored red blood cells despite leukoreduction: a targeted metabolomics study.

Fu X, Felcyn JR, Odem-Davis K, Zimring JC.

Transfusion. 2016 Oct;56(10):2560-2570. doi: 10.1111/trf.13748. Epub 2016 Aug 12.

PMID:
27514704
5.

Metabolites in stored platelets associated with platelet recoveries and survivals.

Zimring JC, Slichter S, Odem-Davis K, Felcyn JR, Kapp LM, Bell LN, Gunst PR, Corson J, Jones MK, Pellham E, Bailey SL, Fu X.

Transfusion. 2016 Aug;56(8):1974-83. doi: 10.1111/trf.13631. Epub 2016 May 9.

PMID:
27158944
6.

Patterns of Care and Survival Outcomes for Malignant Sex Cord Stromal Testicular Cancer: Results from the National Cancer Data Base.

Banerji JS, Odem-Davis K, Wolff EM, Nichols CR, Porter CR.

J Urol. 2016 Oct;196(4):1117-22. doi: 10.1016/j.juro.2016.03.143. Epub 2016 Mar 29.

PMID:
27036305
7.

Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate Cancer.

Pham KN, Cullen J, Hurwitz LM, Wolff EM, Levie KE, Odem-Davis K, Banerji JS, Rosner IL, Brand TC, L'Esperance JO, Sterbis JR, Porter CR.

J Urol. 2016 Aug;196(2):392-8. doi: 10.1016/j.juro.2016.02.2972. Epub 2016 Mar 11.

PMID:
26976206
8.

Lost in translation: signal and frequency amplification in animal modeling.

Zimring JC, Spitalnik SL, Odem-Davis K.

Transfusion. 2016 Mar;56(3):773-4. doi: 10.1111/trf.13457. No abstract available.

PMID:
26954453
9.

Metabolic pathways that correlate with post-transfusion circulation of stored murine red blood cells.

de Wolski K, Fu X, Dumont LJ, Roback JD, Waterman H, Odem-Davis K, Howie HL, Zimring JC.

Haematologica. 2016 May;101(5):578-86. doi: 10.3324/haematol.2015.139139. Epub 2016 Feb 26.

10.

Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.

Roxby AC, Fredricks DN, Odem-Davis K, Ásbjörnsdóttir K, Masese L, Fiedler TL, De Rosa S, Jaoko W, Kiarie JN, Overbaugh J, McClelland RS.

J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):359-66. doi: 10.1097/QAI.0000000000000866.

11.

Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.

Milligan C, Omenda MM, Chohan V, Odem-Davis K, Richardson BA, Nduati R, Overbaugh J.

MBio. 2016 Feb 2;7(1):e02221-15. doi: 10.1128/mBio.02221-15.

12.

Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions.

Waterman HR, Kapp LM, Munday A, Odem-Davis K, Zimring JC.

Transfusion. 2016 Jan;56(1):91-100. doi: 10.1111/trf.13270. Epub 2015 Sep 24.

PMID:
26400622
13.

Prostate Needle Biopsy Outcomes in the Era of the U.S. Preventive Services Task Force Recommendation against Prostate Specific Antigen Based Screening.

Banerji JS, Wolff EM, Massman JD 3rd, Odem-Davis K, Porter CR, Corman JM.

J Urol. 2016 Jan;195(1):66-73. doi: 10.1016/j.juro.2015.07.099. Epub 2015 Aug 6.

PMID:
26254722
14.

A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers.

McClelland RS, Richardson BA, Cherutich P, Mandaliya K, John-Stewart G, Miregwa B, Odem-Davis K, Jaoko W, Kimanga D, Overbaugh J.

AIDS. 2015 Nov;29(17):2279-86. doi: 10.1097/QAD.0000000000000829.

15.
16.

Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?

Pham KN, Porter CR, Odem-Davis K, Wolff EM, Jeldres C, Wei JT, Morgan TM.

J Urol. 2015 Sep;194(3):674-9. doi: 10.1016/j.juro.2015.04.109. Epub 2015 May 9.

PMID:
25963186
17.

Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.

Jeldres C, Cullen J, Hurwitz LM, Wolff EM, Levie KE, Odem-Davis K, Johnston RB, Pham KN, Rosner IL, Brand TC, L'Esperance JO, Sterbis JR, Etzioni R, Porter CR.

Cancer. 2015 Jul 15;121(14):2465-73. doi: 10.1002/cncr.29370. Epub 2015 Apr 6.

18.

Quotidian changes of genital tract cytokines in human immunodeficiency virus-1-infected women during the menstrual cycle.

Cortez V, Odem-Davis K, Lehman DA, Mabuka J, Overbaugh J.

Open Forum Infect Dis. 2014 Mar 31;1(1):ofu002. doi: 10.1093/ofid/ofu002. eCollection 2014 Mar.

19.

On robustness of noninferiority clinical trial designs against bias, variability, and nonconstancy.

Liu Q, Li Y, Odem-Davis K.

J Biopharm Stat. 2015;25(1):206-25. doi: 10.1080/10543406.2014.923738.

20.

Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.

Blish CA, Dogan OC, Jaoko W, McClelland RS, Mandaliya K, Odem-Davis K, Richardson BA, Overbaugh J.

J Virol. 2014 May;88(10):5894-9. doi: 10.1128/JVI.00187-14. Epub 2014 Mar 12.

21.

Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection.

Slyker J, Farquhar C, Atkinson C, Ásbjörnsdóttir K, Roxby A, Drake A, Kiarie J, Wald A, Boeckh M, Richardson B, Odem-Davis K, John-Stewart G, Emery V.

Clin Infect Dis. 2014 Feb;58(4):564-72. doi: 10.1093/cid/cit727. Epub 2013 Nov 5.

22.

Adjusting for unknown bias in non-inferiority clinical trials.

Odem-Davis K, Fleming TR.

Stat Biopharm Res. 2013 Jan 1;5(3). doi: 10.1080/19466315.2013.795910.

23.

Association between alcohol use and sexually transmitted infection incidence among kenyan women engaged in transactional sex.

Wilson KS, Odem-Davis K, Shafi J, Kashonga F, Wanje G, Masese L, Mandaliya K, Jaoko W, McClelland RS.

AIDS Behav. 2014 Jul;18(7):1324-9. doi: 10.1007/s10461-013-0648-0.

24.

HIV-1 superinfection occurs less frequently than initial infection in a cohort of high-risk Kenyan women.

Ronen K, McCoy CO, Matsen FA, Boyd DF, Emery S, Odem-Davis K, Jaoko W, Mandaliya K, McClelland RS, Richardson BA, Overbaugh J.

PLoS Pathog. 2013;9(8):e1003593. doi: 10.1371/journal.ppat.1003593. Epub 2013 Aug 29.

25.

Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection.

Omenda MM, Milligan C, Odem-Davis K, Nduati R, Richardson BA, Lynch J, John-Stewart G, Overbaugh J.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):163-6. doi: 10.1097/QAI.0b013e31829f6e41.

26.

Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy.

Day SL, Odem-Davis K, Mandaliya KN, Jerome KR, Cook L, Masese LN, Scott J, Kim HN, Graham SM, McClelland RS.

PLoS One. 2013;8(3):e59346. doi: 10.1371/journal.pone.0059346. Epub 2013 Mar 18.

27.

Prevalence and correlates of genital warts in Kenyan female sex workers.

Kavanaugh BE, Odem-Davis K, Jaoko W, Estambale B, Kiarie JN, Masese LN, Deya R, Manhart LE, Graham SM, McClelland RS.

Sex Transm Dis. 2012 Nov;39(11):902-5. doi: 10.1097/OLQ.0b013e318275ec7f.

28.

HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.

Mabuka J, Nduati R, Odem-Davis K, Peterson D, Overbaugh J.

PLoS Pathog. 2012;8(6):e1002739. doi: 10.1371/journal.ppat.1002739. Epub 2012 Jun 14.

29.

HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.

Cortez V, Odem-Davis K, McClelland RS, Jaoko W, Overbaugh J.

PLoS Pathog. 2012;8(3):e1002611. doi: 10.1371/journal.ppat.1002611. Epub 2012 Mar 29.

30.

Cellular immune responses and susceptibility to HIV-1 superinfection: a case-control study.

Blish CA, Dogan OC, Jaoko W, McClelland RS, Mandaliya K, Odem-Davis KS, Richardsonb BA, Overbaugh J.

AIDS. 2012 Mar 13;26(5):643-6. doi: 10.1097/QAD.0b013e3283509a0b.

31.

Some essential considerations in the design and conduct of non-inferiority trials.

Fleming TR, Odem-Davis K, Rothmann MD, Li Shen Y.

Clin Trials. 2011 Aug;8(4):432-9. doi: 10.1177/1740774511410994.

Supplemental Content

Loading ...
Support Center